BackApogee Therapeutics Overview

Apogee Therapeutics Total Liabilities

Apogee Therapeutics's total liabilities is $140M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$141.21M
↑ 268.01% YoYΔ $102.84M vs prior year quarter

Peer trimmed avg / median

Loading

Apogee Therapeutics Total Liabilities History

Loading

Apogee Therapeutics vs. peers: Total Liabilities Comparison

Loading

Apogee Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Apogee Therapeutics (APGE) FAQ

As of the most recent data (June 2026), APGE shows a total liabilities of $140M. That compares with $38M in the prior-year period — up 268.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, APGE's total liabilities is now $140M (was $38M) — a 268.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Apogee Therapeutics is outperforming or lagging.

Tracking APGE's total liabilities over time shows whether Apogee Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $140M That compares with $38M in the prior-year period — up 268.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Apogee Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $140M) with ownership activity and broader fundamentals.